Opens in a new tab or window The novel investigational weight loss agent HU6 had mixed results specifically targeting obesity-related heart failure with preserved ejection fraction (HFpEF), based ...

In patients with heart failure (HF) and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), finerenone had a significantly lower rate of worsening ... Or is shockwave therapy the holy grail ...

Once-weekly semaglutide (Wegovy; Novo Nordisk) improves outcomes in patients who have obesity-related heart failure with preserved ejection fraction (HFpEF) across subgroups defined by baseline ...

Discuss the data presented at European Society of Cardiology Congress 2024 on β-blocker (βB) use and outcomes in patients with heart failure with midrange ejection fraction (HFmrEF) and HF with ...

The obese models however, developed heart failure with preserved ejection fraction (HFpEF), proving that a combination of stressors give rise to the disease and providing a good model for further ...

Steroidal mineralocorticoid receptor antagonists lower mortality in patients with heart failure and reduced ejection fraction (HFrEF), but more data are needed about nonsteroidal mineralocorticoid ...

There is rarely a single point of failure to which teams can attribute a breach, but common factors contribute to gaps in risk management efforts and, in turn, cyber incidents. The stakes are ...

The trial was done in adults with obesity and heart failure with preserved ejection fraction (HFpEF). The data, posted online on August 1, has not yet been published in a peer-reviewed journal.

Several possible causes of heart block exist. It may stem from aging of the conduction system, a prior heart attack, heart surgery, medication, or an infection. There are three main types of heart ...

Which mineralocorticoid receptor antagonists (MRAs; ie, steroidal, nonsteroidal) are currently indicated or used for treating heart failure with midrange ejection fraction (HFmrEF) and HF failure ...